⌘K

Login Start Free

Home/Filings/4/0001209191-23-051234

4//SEC Filing

Watkins Thomas 4

Accession 0001209191-23-051234

CIK 0001492426other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 7:32 PM ET

Size

15.8 KB

Accession

0001209191-23-051234

Insider Transaction Report

Form 4

Period: 2023-09-29

Horizon Therapeutics Public Ltd CoHZNP

Director

Transactions

Exercise/Conversion
Stock Option (right to buy)
2023-09-29−20,000→ 0 total
Exercise: $15.96Exp: 2024-06-26→ Ordinary shares (20,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2023-09-29−21,323→ 10,838 total
Exercise: $13.87Exp: 2028-05-02→ Ordinary shares (21,323 underlying)
Exercise/Conversion
Stock Option (right to buy)
2023-09-29−40,000→ 0 total
Exercise: $12.29Exp: 2024-04-14→ Ordinary shares (40,000 underlying)
Exercise/Conversion
Ordinary Shares
2023-09-29$12.29/sh+40,000$491,600→ 69,124 total
Exercise/Conversion
Ordinary Shares
2023-09-29$13.87/sh+21,323$295,750→ 110,447 total
Exercise/Conversion
Ordinary Shares
2023-09-29$15.96/sh+20,000$319,200→ 89,124 total

Holdings

Ordinary Shares
(indirect: By Partnership)
10,000
Ordinary Shares
(indirect: By Trust)
55,953

Footnotes (1)

[F1]The stock option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1

filerCIK 0001307935

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 7:32 PM ET
Size: 15.8 KB

View on SEC.gov